Purple Biotech (PPBT) has released an update. Purple Biotech has identified a new serum biomarker, CEACAM1, which may ...

Nucleai, an AI-powered spatial biology company, will present two abstracts at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting. The presentations will detail how Nucleai's AI-driven ...

Six/UW/Seattle Children’s Cancer Consortium scientists received new funding from the Breast Cancer Research Foundation to ...

A new study has uncovered molecular markers in blood at birth that are linked to later development of acute lymphoblastic ...

Extracellular vesicles are little sacs that can work as a kind of messenger that delivers signals from one cell to another. | ...

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of ...

Monitoring the levels of EVs in the blood could provide direct insight into the level of tissue damage and lead to better cancer detection.

Using computational tools, researchers have developed a method to assess which patients with metastatic triple-negative breast cancer could benefit from immunotherapy.

At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at ...